Rezultati - A Enjalbert
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
-
3
An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in ante... od Laurent Journot, Vincent Homburger, C. Pantaloni, M. Priam, Joël Bockaert, A Enjalbert
Izdano 1987Artigo -
4
-
5
-
6
-
7
The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies od Dermot O’Toole, Alexandru Saveanu, Anne Couvelard, Ginette Gunz, A Enjalbert, P Jaquet, Philippe Ruszniewski, Anne Barlier
Izdano 2006Artigo -
8
-
9
Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph A... od Alexandru Saveanu, Esteban Lavaque, Ginette Gunz, Anne Barlier, S. Kim, John E. Taylor, Michael D. Culler, A Enjalbert, P Jaquet
Izdano 2002Artigo -
10
-
11
-
12
-
13
-
14
-
15
Effect of essential fatty acid deficiency on membrane fatty acid content and growth hormone stimulation of rat pituitaries during postnatal development. od Maria Cristina Flores Soares, M Alessio, C Léger, Marie‐Thérèse Bluet‐Pajot, Hubert Clauser, A Enjalbert, Claude Kordon, D.E. Wandscheer
Izdano 1995Artigo -
16
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. od A Enjalbert, Fritz Sladeczek, Gilles Guillon, P.V. Bertrand, Christine Shu, Jacques Epelbaum, J. Adolfo García‐Sáinz, Serge Jard, Colette Lombard, Claude Kordon
Izdano 1986Artigo -
17
BIM-23244, a Somatostatin Receptor Subtype 2- and 5-Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-Resistant Human GH-Secreting Adenomas... od Alexandru Saveanu, Ginette Gunz, Henry Dufour, P. Caron, F. Fina, L’Houcine Ouafik, Michael D. Culler, J. P. Moreau, A Enjalbert, P Jaquet
Izdano 2001Artigo -
18
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classi... od P Jaquet, Ginette Gunz, Alexandru Saveanu, H. Dufour, John E. Taylor, Jesse Z. Dong, S. Kim, J. P. Moreau, A Enjalbert, Michael D. Culler
Izdano 2005Artigo -
19
Mutations in the<i>Aryl Hydrocarbon Receptor Interacting Protein</i>Gene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas od Anne Barlier, Jean-François Vanbellinghen, Adrian Daly, Monique Silvy, Marie‐Lise Jaffrain‐Rea, Jacqueline Trouillas, Gianluca Tamagno, Laure Cazabat, Vincent Bours, Thierry Brue, A Enjalbert, Albert Beckers
Izdano 2007Artigo -
20
Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms od Rachel Reynaud, F. Albarel, Alexandru Saveanu, N. Kaffel, Frédéric Castinetti, Philippe Lecomte, Raja Brauner, G. Simonin, Jean Gaudart, Eva M. Carmona, A Enjalbert, Anne Barlier, Thierry Brue
Izdano 2011Artigo
Iskalna orodja:
Sorodne teme
Biology
Medicine
Endocrinology
Internal medicine
Gene
Hormone
Genetics
Mutation
Receptor
Chemistry
Growth hormone
Somatostatin
Acromegaly
Anterior pituitary
Prolactin
Somatostatin receptor
Somatostatin receptor 2
Hypopituitarism
Pediatrics
Context (archaeology)
Environmental health
Molecular biology
Octreotide
Paleontology
Population
Adenoma
Agonist
Biochemistry
Cancer research
Dopamine